Top

CardioVascular and Interventional Radiology

Published in:

01-04-2014 | Clinical Investigation

Comparison of Local Control in Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma ≤6 cm With or Without Intraprocedural Monitoring of the Embolized Area Using Cone-Beam Computed Tomography

Authors: Shiro Miyayama, Masashi Yamashiro, Masahiro Hashimoto, Nanako Hashimoto, Masaya Ikuno, Kenichiro Okumura, Miki Yoshida, Osamu Matsui

Published in: CardioVascular and Interventional Radiology | Issue 2/2014

Abstract

Purpose

This study was designed to compare technical success and local recurrence rates of transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) with/without monitoring of embolized areas using cone-beam computed tomography (CBCT).

Methods

A total of 207 HCCs ≤6 cm were treated with superselective TACE using digital subtraction angiography (DSA) alone (DSA group, 98 tumors of 70 patients) or plus CBCT monitoring (CBCT group, 109 tumors of 79 patients). Technical success of TACE was classified into three grades according to 1-week CT; the tumor was embolized with a safety margin (5-mm wide for tumors <25 mm, and 10-mm wide for tumors 25≥ and ≤60 mm; grade A), without a margin in parts (grade B), or the entire tumor was not embolized (grade C). Technical success and local recurrence rates in the DSA and CBCT groups were compared. Local recurrence rates of grade A and B tumors were also compared.

Results

The grade A/B/C tumors in the DSA and CBCT groups were 64 (65.3 %)/25 (25.5 %)/9 (9.2 %) and 95 (87.2 %)/11 (10.1 %)/3 (2.8 %), respectively. Local recurrence developed in 46/158 (29.1 %) grade A tumors and 24/36 (66.7 %) grade B. There were significant differences in technical success between the DSA and CBCT groups (p < 0.001) and local recurrence rates between grade A and B tumors (p < 0.001). The 1-, 2-, and 3-year local recurrence rates in the DSA and CBCT groups were 33.3 and 22.3 %, 41.3 and 26.8 %, and 48 and 30.6 %, respectively (p = 0.0217).

Conclusion

Intraprocedural CBCT monitoring of embolized areas reduces the local tumor recurrence.

Yamada R, Sato M, Kawabata M et al (1983) Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 148:397–401PubMed

Uchida H, Ohishi H, Matsuo N et al (1990) Transcatheter hepatic segmental arterial embolization using lipiodol mixed with an anticancer drug and Gelfoam particles for hepatocellular carcinoma. Cardiovasc Intervent Radiol 13:140–145PubMedCrossRef

Matsui O, Kadoya M, Yoshikawa J et al (1993) Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology 188:79–83PubMed

Takayasu K, Muramatsu Y, Maeda T et al (2001) Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. AJR Am J Roentogenol 176:681–688CrossRef

Ishijima H, Koyama Y, Aoki J et al (1999) Use of a combined CT-angiography system for demonstration of correlative anatomy during embolotherapy for hepatocellular carcinoma. J Vasc Interv Radiol 10:811–815PubMedCrossRef

Miyayama S, Matsui O, Yamashiro M et al (2007) Ultraselective transcatheter arterial chemoembolization with a 2-F tip microcatheter for small hepatocellular carcinomas: relationship between local tumor recurrence and visualization of the portal vein with iodized oil. J Vasc Interv Radiol 18:365–376PubMedCrossRef

Morimoto M, Numata K, Sugimori K et al (2007) Successful initial ablation therapy contributes to survival in patients with hepatocellular carcinoma. World J Gastroenterol 13:1003–1009PubMed

Miyayama S, Yamashiro M, Okuda M et al (2009) Usefulness of cone-beam computed tomography during ultraselective transcatheter arterial chemoembolization for small hepatocellular carcinomas that cannot be demonstrated on angiography. Cardiovasc Intervent Radiol 32:255–264PubMedCrossRef

Hirota S, Nakao N, Yamamoto S et al (2006) Cone-beam CT with flat-panel-detector digital angiography system: early experience in abdominal interventional procedures. Cardiovasc Intervent Radiol 29:1034–1038PubMedCrossRef

10.

Virmani S, Ryu RK, Sato KT et al (2007) Effect of C-arm angiographic CT on transcatheter arterial chemoembolization of liver tumors. J Vasc Interv Radiol 18:1305–1309PubMedCrossRef

11.

Wallace MJ, Murthy R, Kamat PP et al (2007) Impact of C-arm CT on hepatic arterial interventions for hepatic malignancies. J Vasc Interv Radiol 18:1500–1507PubMedCrossRef

12.

Kakeda S, Korogi Y, Ohnari N et al (2007) Usefulness of cone-beam volume CT with flat panel detectors in conjunction with catheter angiography for transcatheter arterial embolization. J Vasc Interv Radiol 18:1508–1516PubMedCrossRef

13.

Miyayama S, Matsui O, Yamashiro M et al (2009) Detection of hepatocellular carcinoma by CT during arterial portography using a cone-beam CT technology: comparison with conventional CTAP. Abdom Imaging 34:502–506PubMedCrossRef

14.

Miyayama S, Yamashiro M, Hattori Y et al (2011) Efficacy of cone-beam computed tomography during transcatheter arterial chemoembolization for hepatocellular carcinoma. Jpn J Radiol 29:371–377PubMedCrossRef

15.

Iwazawa J, Ohue S, Hashimoto N et al (2012) Survival after C-arm CT-assisted chemoembolization of unresectable hepatocellular carcinoma. Eur J Radiol 81:3985–3992PubMedCrossRef

16.

Mori H, Saida Y, Wanatane Y et al (2000) Rapid production of gelatin sponge particles for transcatheter arterial embolization: pumping method. Nippon Acta Radiol 60:702–704 (in Japanese)PubMed

17.

Sasaki A, Kai S, Iwashita Y et al (2005) Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma. Cancer 103:299–306PubMedCrossRef

18.

Higashihara H, Okazaki M (2002) Transcatheter arterial chemoembolization of hepatocellular carcinoma: a Japanese experience. Hepatogastroenterology 49:72–78PubMed

19.

Nakazawa T, Kokubu S, Shibuya A et al (2007) Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. AJR Am J Roentgenol 188:480–488PubMedCrossRef

20.

Kim YS, Lee WJ, Rhim H et al (2010) The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (>2 and <5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. AJR Am J Roentogenol 195:758–765CrossRef

21.

Ueda K, Saito K, Terada T et al (1991) Selective necrosis of encapsulated malignant lesion within atypical adenomatous hyperplasia of the liver following transarterial embolization. a report of two autopsy cases. J Clin Gastroenterol 13:709–714PubMedCrossRef

22.

Takayasu K, Wakao F, Moriyama N et al (1993) Response of early-stage hepatocellular carcinoma and borderline lesions to therapeutic arterial embolization. AJR Am J Roentogenol 160:301–306CrossRef

23.

Miyayama S, Matsui O, Yamashiro M et al (2007) Iodized oil accumulation in the hypovascular tumor portion of early-stage hepatocellular carcinoma after ultraselective transcatheter arterial chemoembolization. Hepatol Int 1:451–459PubMedCentralPubMedCrossRef

24.

Iwazawa J, Ohue S, Kitayama T et al (2011) C-arm CT for assessing initial failure of iodized oil accumulation in chemoembolization of hepatocellular carcinoma. AJR Am J Roentgenol 197:W337–W342PubMedCrossRef

25.

Terayama N, Matsui O, Gabata T et al (2001) Accumulation of iodized oil within the nonneoplastic liver adjacent to hepatocellular carcinoma via the drainage routes of the tumor after transcatheter arterial embolization. Cardiovasc Intervent Radiol 24:383–387PubMedCrossRef

26.

Miyayama S, Mitsui T, Zen Y et al (2009) Histopathological findings after ultraselective transcatheter arterial chemoembolization for hepatocellular carcinoma. Hepatol Res 39:374–381PubMedCrossRef

27.

Yamanaka K, Hatano E, Kitamura K et al (2012) Early evaluation of transcatheter arterial chemoembolization-refractory hepatocellular carcinoma. J Gastroenterol 47:343–346PubMedCrossRef

28.

Miyayama S, Yamashiro M, Hashimoto M et al (2013) Identification of small hepatocellular carcinoma and tumor-feeding branches with cone-beam CT guidance technology during transcatheter arterial chemoembolization. J Vasc Interv Radiol 24:501–508PubMedCrossRef

Title: Comparison of Local Control in Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma ≤6 cm With or Without Intraprocedural Monitoring of the Embolized Area Using Cone-Beam Computed Tomography
Authors: Shiro Miyayama
Masashi Yamashiro
Masahiro Hashimoto
Nanako Hashimoto
Masaya Ikuno
Kenichiro Okumura
Miki Yoshida
Osamu Matsui
Publication date: 01-04-2014
Publisher: Springer US
Published in: CardioVascular and Interventional Radiology / Issue 2/2014
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI: https://doi.org/10.1007/s00270-013-0667-2

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Comparison of Local Control in Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma ≤6 cm With or Without Intraprocedural Monitoring of the Embolized Area Using Cone-Beam Computed Tomography

Abstract

Purpose

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2014

Transrenal Ureteral Occlusion Using the Amplatzer Vascular Plug II: A New Interventional Treatment Option for Lower Urinary Tract Fistulas

Massive Subcutaneous and Mediastinal Emphysema with Little Pneumothorax Treated by Surgery after Pulmonary Radiofrequency Ablation

Comparison of Endovascular and Open Repair of Ruptured Abdominal Aortic Aneurysm in the United States in the Past Decade

Anatomic Risk Factors for Type-2 Endoleak Following EVAR: A Retrospective Review of Preoperative CT Angiography in 326 patients

High-Pitch Carbon Dioxide Contrasted CT Angiography: Pilot Study

A Case of Pulmonary Aspergilloma Treated with Radiofrequency Ablation